Royal Bank of Canada’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.11M | Buy |
986,300
+932,439
| +1,731% | +$1.05M | ﹤0.01% | 3500 |
|
2025
Q1 | $79K | Buy |
53,861
+20,101
| +60% | +$29.5K | ﹤0.01% | 4991 |
|
2024
Q4 | $72K | Buy |
33,760
+1,669
| +5% | +$3.56K | ﹤0.01% | 5033 |
|
2024
Q3 | $90K | Buy |
32,091
+3,077
| +11% | +$8.63K | ﹤0.01% | 4960 |
|
2024
Q2 | $67K | Sell |
29,014
-15,707
| -35% | -$36.3K | ﹤0.01% | 5124 |
|
2024
Q1 | $200K | Sell |
44,721
-18,088
| -29% | -$80.9K | ﹤0.01% | 4261 |
|
2023
Q4 | $202K | Buy |
62,809
+6,362
| +11% | +$20.5K | ﹤0.01% | 4570 |
|
2023
Q3 | $179K | Buy |
56,447
+7,473
| +15% | +$23.7K | ﹤0.01% | 4430 |
|
2023
Q2 | $244K | Buy |
48,974
+4,104
| +9% | +$20.4K | ﹤0.01% | 4146 |
|
2023
Q1 | $221K | Buy |
44,870
+2,962
| +7% | +$14.6K | ﹤0.01% | 4167 |
|
2022
Q4 | $264K | Sell |
41,908
-1,396
| -3% | -$8.79K | ﹤0.01% | 4184 |
|
2022
Q3 | $468K | Sell |
43,304
-186
| -0.4% | -$2.01K | ﹤0.01% | 3633 |
|
2022
Q2 | $495K | Sell |
43,490
-3,429
| -7% | -$39K | ﹤0.01% | 3681 |
|
2022
Q1 | $427K | Sell |
46,919
-18,066
| -28% | -$164K | ﹤0.01% | 3945 |
|
2021
Q4 | $970K | Sell |
64,985
-29,052
| -31% | -$434K | ﹤0.01% | 3362 |
|
2021
Q3 | $2.42M | Buy |
94,037
+971
| +1% | +$25K | ﹤0.01% | 2535 |
|
2021
Q2 | $2.43M | Buy |
93,066
+2,275
| +3% | +$59.3K | ﹤0.01% | 2554 |
|
2021
Q1 | $3.21M | Buy |
90,791
+47,756
| +111% | +$1.69M | ﹤0.01% | 2286 |
|
2020
Q4 | $1.09M | Buy |
43,035
+1,814
| +4% | +$45.8K | ﹤0.01% | 2969 |
|
2020
Q3 | $1.55M | Sell |
41,221
-12,971
| -24% | -$489K | ﹤0.01% | 2527 |
|
2020
Q2 | $2.32M | Buy |
54,192
+15,895
| +42% | +$681K | ﹤0.01% | 2185 |
|
2020
Q1 | $744K | Buy |
38,297
+1,349
| +4% | +$26.2K | ﹤0.01% | 2869 |
|
2019
Q4 | $960K | Buy |
36,948
+6,731
| +22% | +$175K | ﹤0.01% | 2949 |
|
2019
Q3 | $824K | Buy |
30,217
+7,241
| +32% | +$197K | ﹤0.01% | 2984 |
|
2019
Q2 | $617K | Buy |
22,976
+5,591
| +32% | +$150K | ﹤0.01% | 3201 |
|
2019
Q1 | $503K | Sell |
17,385
-407
| -2% | -$11.8K | ﹤0.01% | 3215 |
|
2018
Q4 | $479K | Buy |
+17,792
| New | +$479K | ﹤0.01% | 3163 |
|